ebe013b6-6773-4418-bc34-673dfb564248.pdf



REPORT FOR SECOND QUARTER FY16



Antaria Limited is a specialist manufacturer and supplier of materials used in the personal care and cosmetic sectors.

Antaria's two primary products are ZinClear™ a transparent zinc oxide based broad spectrum UV absorber for use in the sun care and cosmetics sector and Alusion™ an aluminium oxide pigment with applications in cosmetics products.

Antaria services its international customer-­‐base via a global network of distributors.


ASX: ANO


Directors

Rade Dudurovic (Chairman) Ron Higham

Lev Mizikovsky


Company Secretary

Geoff Acton

Quarterly Overview

 Cash flow from operations for the December 2015 quarter was an outflow of $317,200 compared to an outflow of

$180,986 for the December 2014 quarter, reflecting the seasonality in Antaria's sales and receipts cycle.

 The quarter showed a continuation of the positive growth in sales, particularly of the ZinClearTM range of products, resulting in strong invoicing during the quarter with receivables totalling $1.412 million at 31 December 2015 compared with $1.244 million at 31 December 2014. The prior year receivables balance however included a Research & Development receivable of $0.344 million, whereas the 31 December 2015 balance does not, as the R&D claim for the 2015 financial year is still being finalised and will be lodged and accounted for in the 3rd quarter of FY16.

 The collection of the outstanding receivables balance at 31 December 2015 will benefit cash flow in the 3rd quarter of FY 16.

 Demand for the ZinClearTM range of products continues to improve due to the expansion of the distribution network and as a result of the investment in new formulations and samples. ZinClearTM revenues in the quarter grew by 46% over the December 2014 quarter.

 AlusionTM revenues, coming off a low base, were 91% higher than the December 2014 quarter, reflecting the resumption of sales to Merck KgaA. Antaria is in the early stages of a commercial dispute with Merck KgaA and this may affect sales of AlusionTM in the next 12 months.

 Antaria's cash balance at the end of the quarter was

$670,675 up from $608,223 as at 30 June 2015.

For further information, please contact: Rade Dudurovic - Non Executive Chairman Email: rade.antaria@gmail.com

Mobile: +61 411 72 62 84


ANO -­‐ Quarterly Commentary -­‐ 31 Dec 2015.doc 1 of 1

Antaria Limited issued this content on 29 January 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 29 January 2016 01:09:08 UTC

Original Document: http://www.antaria.com/IRM/PDF/1666/Appendix4Cquarterlycommentary31December2015